Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeStance Health (LFST) EPS (Weighted Average and Diluted) (2021 - 2025)

LifeStance Health (LFST) has disclosed EPS (Weighted Average and Diluted) for 5 consecutive years, with $0.03 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 250.0% to $0.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.02 through Dec 2025, up 112.5% year-over-year, with the annual reading at $0.02 for FY2025, 113.33% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.03 at LifeStance Health, up from -$0.01 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.03 in Q4 2025, with the low at -$329.84 in Q4 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$20.71, with a median of -$0.12 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 54.55% in 2023, then skyrocketed 250.0% in 2025.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$329.84 in 2021, then surged by 99.96% to -$0.13 in 2022, then grew by 7.69% to -$0.12 in 2023, then soared by 83.33% to -$0.02 in 2024, then surged by 250.0% to $0.03 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.03, -$0.01, and -$0.02 for Q4 2025, Q2 2025, and Q4 2024 respectively.